Vergelijking

Buserelin vs. Carbetocin

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

57982-77-1

37025-55-1

Molecuulmassa

1239.42 g/mol

geen gegevens

Halfwaardetijd

geen gegevens

0.67 h

Sequentie

geen gegevens

Werkingsmechanisme

Buserelin

Buserelin is a potent GnRH agonist: after an initial stimulatory surge ('flare'), continuous receptor occupancy causes downregulation and thereby suppression of LH, FSH and the downstream sex hormones.

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Buserelin	Carbetocin
Duitsland	Op recept	Op recept
Verenigde Staten	Niet goedgekeurd	Niet goedgekeurd

Volledige vermeldingen

Buserelin

Volledige vermelding →

Carbetocin

Volledige vermelding →

Frequently asked questions

What is the difference between Buserelin and Carbetocin?: Buserelin is classified as "Onderzoek (overig)", while Carbetocin is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Buserelin or Carbetocin?: The highest available evidence level is "Humane RCT" for Buserelin and "Humane RCT" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Buserelin and Carbetocin in Germany and the United States?: Duitsland: Buserelin — Op recept, Carbetocin — Op recept. Verenigde Staten: Buserelin — Niet goedgekeurd, Carbetocin — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Buserelin

Carbetocin

Duitsland

Op recept

Verenigde Staten

Niet goedgekeurd

Frequently asked questions

What is the difference between Buserelin and Carbetocin?

Buserelin is classified as "Onderzoek (overig)", while Carbetocin is classified as "Onderzoek (overig)". Buserelin: Buserelin is a synthetic GnRH agonist (including as a nasal spray). It is used in endometriosis, hormone-dependent prostate cancer and assisted reproduction; approved in Europe (Suprefact), not in the US. Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Buserelin or Carbetocin?

The highest available evidence level is "Humane RCT" for Buserelin and "Humane RCT" for Carbetocin. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Buserelin and Carbetocin in Germany and the United States?

Duitsland: Buserelin — Op recept, Carbetocin — Op recept. Verenigde Staten: Buserelin — Niet goedgekeurd, Carbetocin — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.